{"title":"RNA-binding proteins regulate immune-related alternative splicing in inherited salt-losing tubulopathies.","authors":"Fuhui Ma, Yanrong Ma, Mayinu Yusufu, Reziwanguli Wusiman, Shuqing Xing, Xiangxin Song, Suli Li, Yanying Guo","doi":"10.1186/s13023-025-03972-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inherited salt-losing tubulopathies (SLT) are rare disorders caused by gene mutations that disrupt renal tubular ion transport. However, the molecular mechanisms underlying SLT pathogenesis remain unclear. This study aims to elucidate the functional genes and potential regulatory mechanisms associated with SLT.</p><p><strong>Methods: </strong>We established a study cohort comprising inherited SLT patients, age-matched patients with acquired hypokalemia, and healthy volunteers. Clinical characteristics were compared among the groups. RNA sequencing (RNA-seq) was performed to obtain transcriptomic profiles, followed by analysis of gene expression patterns and alternative splicing events (ASEs). Key findings were validated using RT-qPCR.</p><p><strong>Results: </strong>SLT patients exhibited a higher prevalence of recurrent viral infections (65%, P = 0.004) and autoimmune thyroid disorders (30%, P = 0.022) compared to healthy controls. RNA-seq analysis identified 2,611 differentially expressed genes (DEGs) in SLT patients, including 1,236 upregulated and 1,375 downregulated genes. These DEGs were primarily enriched in innate immune responses and adaptive immunity pathways. Additionally, significant alterations in gene expression related to viral defense and stress responses were observed. Notably, we identified several RNA-binding proteins (RBPs) that may contribute to SLT pathogenesis by regulating ASEs of immune-related genes.</p><p><strong>Conclusion: </strong>Our findings highlight the critical role of RBPs in SLT pathogenesis and provide novel insights into the immune profiles and gene expression dynamics in SLT. This study lays the foundation for future research into targeted therapies and personalized treatment strategies for SLT management.</p>","PeriodicalId":19651,"journal":{"name":"Orphanet Journal of Rare Diseases","volume":"20 1","pages":"416"},"PeriodicalIF":3.5000,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335119/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orphanet Journal of Rare Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13023-025-03972-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Inherited salt-losing tubulopathies (SLT) are rare disorders caused by gene mutations that disrupt renal tubular ion transport. However, the molecular mechanisms underlying SLT pathogenesis remain unclear. This study aims to elucidate the functional genes and potential regulatory mechanisms associated with SLT.
Methods: We established a study cohort comprising inherited SLT patients, age-matched patients with acquired hypokalemia, and healthy volunteers. Clinical characteristics were compared among the groups. RNA sequencing (RNA-seq) was performed to obtain transcriptomic profiles, followed by analysis of gene expression patterns and alternative splicing events (ASEs). Key findings were validated using RT-qPCR.
Results: SLT patients exhibited a higher prevalence of recurrent viral infections (65%, P = 0.004) and autoimmune thyroid disorders (30%, P = 0.022) compared to healthy controls. RNA-seq analysis identified 2,611 differentially expressed genes (DEGs) in SLT patients, including 1,236 upregulated and 1,375 downregulated genes. These DEGs were primarily enriched in innate immune responses and adaptive immunity pathways. Additionally, significant alterations in gene expression related to viral defense and stress responses were observed. Notably, we identified several RNA-binding proteins (RBPs) that may contribute to SLT pathogenesis by regulating ASEs of immune-related genes.
Conclusion: Our findings highlight the critical role of RBPs in SLT pathogenesis and provide novel insights into the immune profiles and gene expression dynamics in SLT. This study lays the foundation for future research into targeted therapies and personalized treatment strategies for SLT management.
期刊介绍:
Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.